Lv1
80 积分 2025-07-31 加入
Sintilimab and lenvatinib plus hepatic arterial infusion chemotherapy and embolization as conversion therapy for uHCC: A phase 2 trial
1天前
已完结
Sintilimab and lenvatinib plus hepatic arterial infusion chemotherapy and embolization as conversion therapy for uHCC: A phase 2 trial
1天前
已关闭
Neoadjuvant mFOLFOXIRI with or without cadonilimab versus mFOLFOX6 in locally advanced colorectal cancer: A randomized phase 2 trial (OPTICAL-2)
1天前
已完结
Neoadjuvant mFOLFOXIRI with or without cadonilimab versus mFOLFOX6 in locally advanced colorectal cancer: A randomized phase 2 trial (OPTICAL-2)
2天前
已关闭
[Clouds move aside to pour the moonlight: the past and present of antiphospholipid syndrome]
1个月前
已完结
How I diagnose and treat acute infection–associated purpura fulminans
1个月前
已完结
Dose-dependent pharmacological mechanisms within the Neuroscience-based Nomenclature: a new concept to facilitate neuroscience-based prescribing
3个月前
已完结
2025 Update on MRD in Acute Myeloid Leukemia: A Consensus Document from the ELN-DAVID MRD Working Party
4个月前
已完结
Talquetamab plus daratumumab for the treatment of relapsed or refractory multiple myeloma in the TRIMM-2 study
5个月前
已完结
How I Treat Advanced Phases of CML
5个月前
已关闭
皖公网安备34019202002308
